文献速递眼底病与葡萄膜炎眼外伤

肠球菌性眼内炎:临床特征、抗菌药物敏感性及治疗结局

ENTEROCOCCUS ENDOPHTHALMITIS: Clinical Settings, Antimicrobial Susceptibility, and Management Outcomes.
PubMed 文献 · Retina · 2020-01-01

回顾性分析29例培养证实的肠球菌性眼内炎,开放 globe 损伤最常见(62%),以 E. casseliflavus 为主(48.27%),万古霉素敏感率93%。最终视力≥20/400 者占34.48%,解剖成功占62%,角膜受累高达82.75%。

要点

  • 开放 globe 损伤是肠球菌性眼内炎最常见诱因。
  • E. casseliflavus 最常见,万古霉素敏感率93%。
  • 尽管治疗及时,视力预后仍差。

核心结论

  • 肠球菌是开放 globe 损伤后眼内炎中不可忽视的病原体,万古霉素耐药罕见,多药耐药仅见于 E. faecalis。
  • 尽管早期适当治疗,因病原体固有毒力,视力结局仍差。

研究设计与样本

  • 回顾性病例系列,纳入2005年1月至2018年5月培养证实的肠球菌性眼内炎29例,均行玻璃体切除/玻璃体活检及玻璃体腔抗生素注射,伴或不伴其他操作。

主要发现

  • 患者中男性24例(82.8%),平均年龄32.89±25.25岁(中位数24岁)。
  • 诱因:开放 globe 损伤18例(62%)、内源性5例(17.24%)、白内障术后3例(10.34%)、巩膜扣带术后2例(6.89%)、角膜移植术后1例(3.44%)。
  • 最常见菌种为 E. casseliflavus(14/29,48.27%),其次为 E. faecalis(9/29,31%)。
  • 万古霉素敏感27/29株(93%)。
  • 初诊时所有眼视力≤20/400,最终视力≥20/400者10/29例(34.48%)。

关键数值与推荐

  • 解剖成功定义为保留眼球、无低眼压、视网膜在位及末次随访无活动性炎症。
  • 视力成功定义为最终视力≥20/400。

临床怎么用

  • 对开放 globe 损伤后眼内炎应考虑到肠球菌可能,万古霉素可作为经验性覆盖选择。
  • 肠球菌性眼内炎视力预后差,需早期积极干预并管理角膜受累。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the clinical presentation and management outcome of patients with endophthalmitis caused by Enterococcus species and to report the susceptibility profile of the isolates. METHODS: Twenty-nine cases with culture-proven Enterococcus endophthalmitis from January 2005 to May 2018 underwent vitrectomy/vitreous biopsy, intravitreal antibiotic with or without additional procedures. The undiluted vitreous was subjected to microbiologic evaluation. A favorable anatomical outcome was defined as preservation of the globe, absence of hypotony, attached retina, and absence of active inflammation at the last visit. Favorable visual outcome was final visual acuity ≥20/400. RESULTS: There were 24 men (82.8%). Mean age at presentation was 32.89 ± 25.25 years (median 24 years). Inciting event was open globe injury in 18 (62%), endogenous in 5 (17.24%), postcataract surgery in 3 (10.34%), postscleral buckling in 2 (6.89%), and postkeratoplasty in 1 (3.44%). Enterococcus casseliflavus was the commonest species isolated (14/29, 48.27%) followed by E. faecalis (9/29, 31%). Susceptibility to vancomycin was seen in 27/29 isolates (93%). Visual acuity was ≤20/400 in all eyes at presentation and ≥20/400 in 10/29 cases (34.48%) at final visit. Anatomical success was seen in 18/29 eyes (62%). Corneal involvement was high at 24/29 eyes (82.75%). CONCLUSION: Enterococcus is not an uncommon organism in the setting of endophthalmitis after open globe injury. Resistance to vancomycin is rare. Multidrug resistance pattern is restricted to E. faecalis. Visual outcome is poor despite early and appropriate therapy due to inherent organism virulence.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Dave VP, Pathengay A, Braimah IZ, et al. ENTEROCOCCUS ENDOPHTHALMITIS: Clinical Settings, Antimicrobial Susceptibility, and Management Outcomes. Retina. 2020. PMID: 30681640. doi:10.1097/IAE.0000000000002462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。